Group 1 - Baiyun Airport announces joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds 51% [3] - Dongxing Medical plans to acquire 90% stake in Wuhan Yijiaobao, a high-tech company focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary plans to transfer 100% stake in Shanghai Clone to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Group 2 - Hengxing Technology's subsidiary is awaiting approval for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [6] - New Sai Co. announces resignation of its general manager Chen Jianjiang due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [8] Group 3 - Zhejiang University Network plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] - Huazhong Precision terminates the issuance of A-shares to specific targets, affecting a control acquisition [10] - Jiaze New Energy states that its green chemical business is not yet commercially viable, with no significant impact on revenue or profit in the short term [11] Group 4 - Hailan Home plans to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [12] - Hongfuhang intends to invest up to 1.128 billion yuan in a joint venture to build a photovoltaic energy storage project in Congo [13] - Zhongchuang Zhiling plans to invest 5 billion yuan in a new energy vehicle parts industrial base and R&D center [14] Group 5 - Haitai Development's subsidiary signs a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [15] - Dongjie Intelligent's overseas subsidiary secures a procurement order worth approximately 180 million yuan, representing 22.3% of its audited revenue for 2024 [17] - Zhiguang Electric's subsidiary signs a procurement contract worth 164 million yuan for energy storage systems [18] Group 6 - ST Songfa's subsidiary signs a shipbuilding contract for four VLCCs, with a contract value between 400 million to 600 million USD [19] - Huaguang Huaneng signs a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [20] - Yousheng Co. receives a project notification from a German automaker, with total sales expected to reach approximately 2.3 billion yuan [24] Group 7 - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [25] - Compton plans to reduce holdings of repurchased shares by up to 1% [26] - Aored plans to reduce holdings of repurchased shares by up to 1.29% [27] Group 8 - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a new materials project [34] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [33] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production facility upgrades and working capital [34]

Major Events - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company at Guangzhou Baiyun Airport with a registered capital of 45 million yuan, where China Duty Free will contribute 22.95 million yuan for a 51% stake [4] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao's equity for cash, which is expected to constitute a major asset restructuring [5] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Clon to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [7] - Hengxing Technology's subsidiary is undergoing a review for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [8] - New Sai Co.'s general manager Chen Jianjiang resigned due to work adjustments [9] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [10] - Zhejiang University Net announced plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [11] - Huazhong Precision terminated its plan to issue A-shares to specific investors, which also halts the acquisition of control by a third party [12] - Jiazhe New Energy stated that its green chemical business is not yet commercially viable [13] Significant Contracts - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [18] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [19][20] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for energy storage systems [21] - ST Songfa's subsidiary signed contracts for building four oil tankers, with a total value between 400 million to 600 million USD [22] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [23] - Keda Intelligent plans to issue H-shares and list on the Hong Kong Stock Exchange, with details still under discussion [24] Shareholding Changes - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [28] - Compton plans to reduce up to 1% of its repurchased shares [29] - Aorede plans to reduce up to 1.29% of its shares from the repurchased stock [30] - Yidian Tianxia's controlling shareholder plans to reduce up to 3% of its shares [31] - Huace Film's shareholders plan to transfer 3.6% of the company's shares through an inquiry transfer [32] Buybacks and Financing - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase [33] - CanSino plans to cancel 406,100 repurchased shares and reduce registered capital accordingly [35] Fundraising Initiatives - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [36] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [37] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production line upgrades and working capital [38]

Joint Ventures and Investments - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds a 51% stake [3] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao Biological Materials Co., a high-tech enterprise focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Cloning's equity to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Corporate Actions - New Sai Co. announced the resignation of its director and general manager, Chen Jianjiang, due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [8] - Zhejiang University Network New plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] Contracts and Orders - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase the company's profit by approximately 62.86 million yuan in 2025 [12] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [13] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for high-voltage energy storage systems [14] - ST Songfa's subsidiary signed contracts for the construction of four oil tankers, with a total contract value between 400 million to 600 million USD [15] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [16] Regulatory and Compliance - Jingliang Holdings received an administrative regulatory decision from Hainan Securities Regulatory Bureau for violations related to trade activities, involving an income amount of 299 million yuan [18] Shareholder Actions - Zaiseng Technology's controlling shareholder plans to reduce its stake by up to 3%, amounting to approximately 30.9 million shares [20] - Compton plans to reduce its repurchased shares by up to 1%, totaling approximately 2.5644 million shares [21] Financing Activities - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase from Industrial and Commercial Bank of China [23] - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [25]

Core Viewpoint - Hailiang Co., Ltd. plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and international competitiveness [1] Group 1 - The company aims to deepen its globalization strategy and improve its international image [1] - The company is in discussions with relevant intermediaries regarding the H-share issuance and listing [1] - Specific details of the H-share issuance and listing are yet to be finalized [1]

Core Viewpoint - Zhejiang Hailiang Co., Ltd. plans to issue H-shares and list on the Hong Kong Stock Exchange to advance its globalization strategy, although details are still under discussion and the implementation carries significant uncertainty [1] Group 1: Company Strategy - The company aims to deepen its global strategy through the proposed issuance of H-shares [1] - Discussions with relevant intermediaries are currently underway to explore the specifics of the H-share issuance [1] Group 2: Regulatory Considerations - The proposed H-share issuance and listing will require approval from the company's board and shareholders [1] - Approval from regulatory bodies such as the China Securities Regulatory Commission and the Hong Kong Stock Exchange is also necessary, adding to the uncertainty of the plan's execution [1]

Core Viewpoint - Hailiang Co., Ltd. is planning to issue H-shares and list on the main board of the Hong Kong Stock Exchange, with discussions ongoing with relevant intermediaries regarding the issuance and listing details [1] Group 1 - The company announced on September 26 that it is in the process of planning the issuance of H-shares [1] - The details of the H-share issuance and listing have not yet been finalized [1]

Core Viewpoint - Hailiang Co., Ltd. plans to issue shares overseas (H-shares) and list on the main board of the Hong Kong Stock Exchange [1] Group 1 - The company announced its intention to raise funds through the issuance of H-shares [1] - The listing is aimed at expanding the company's capital base and enhancing its market presence [1]

| 证券代码：002203 | 证券简称：海亮股份 | 公告编号：2025-099 | | --- | --- | --- | | 债券代码：128081 | 债券简称：海亮转债 | | 特此公告 浙江海亮股份有限公司 董事会 二〇二五年九月二十七日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 根据浙江海亮股份有限公司（下称"公司"）总体发展战略及运营需要，为 深入推进全球化战略，提升公司国际形象及综合竞争力，加强与境外资本市场 对接，公司拟筹划在境外发行股份（H 股）并在香港联合交易所有限公司（下 称"香港联交所"）主板挂牌上市（下称"本次 H 股发行上市"）。截至目前，公 司正计划与相关中介机构就本次 H 股发行上市的相关工作进行商讨，相关细节 尚未最终确定。 根据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易 所股票上市规则》《境内企业境外发行证券和上市管理试行办法》《香港联合交 易所有限公司证券上市规则》以及中国香港法律对在中国境内注册成立的发行 人在香港发行股票并上市等相关法律法规的要求，待确定具体方案后，本次 H 股发行上市尚需 ...

Core Viewpoint - Hailiang Co., Ltd. plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and international competitiveness [1] Group 1 - The company aims to deepen its globalization strategy and improve its international image [1] - The company is currently in discussions with relevant intermediaries regarding the H-share issuance and listing [1] - Specific details of the H-share issuance and listing have not yet been finalized [1]

Core Viewpoint - Zhejiang Hailiang Co., Ltd. plans to issue H-shares and list on the Hong Kong Stock Exchange to advance its globalization strategy, with details still under discussion [1] Group 1: Company Strategy - The company aims to deepen its global strategy through the proposed issuance of H-shares [1] - Discussions with relevant intermediaries are currently ongoing to outline the specifics of the H-share issuance [1] Group 2: Regulatory Process - The H-share issuance and listing will require approval from the company's board and shareholders, as well as regulatory bodies including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [1] - There is significant uncertainty regarding the final implementation of the H-share issuance [1] Group 3: Investor Communication - The company will provide timely updates on the progress of the H-share issuance and advises investors to pay attention to subsequent announcements and investment risks [1]